K. Ohman

发表

Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.

J. Rosenstock, B. Goldstein, D. Anzalone, 2006, Current medical research and opinion.

A population study of plasma neuropeptide Y: correlations with components of the metabolic syndrome.

P. Nilsson, B. Karlberg, F. Nyström, 1996, Blood pressure.

Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease.

J. Ahlner, E. Swahn, N. Nielsen, 1999, Scandinavian journal of clinical and laboratory investigation.

Endothelin-induced vasoconstriction and release of atrial natriuretic peptides in the rat.

H. Keiser, A. Hoffman, K. Ohman, 1990, Acta physiologica Scandinavica.

Endothelin induces an initial increase in cardiac output associated with selective vasodilation in rats.

H. Keiser, E. Marks, E. Grossman, 1989, Life sciences.

Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.

B. Karlberg, K. Ohman, K. P. Ohman, 1991, Clinical science.

Atrial natriuretic factor (ANF 103-126) enhances volume- and pressor-induced heart rate response in the conscious rat.

H. Keiser, E. Marks, K. Ohman, 1990, Acta physiologica Scandinavica.

Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity.

B. Karlberg, J. Asplund, O. Nilsson, 2009, Acta medica Scandinavica.

Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.

B. Karlberg, O. Nilsson, S. Wettre, 2009, Acta medica Scandinavica. Supplementum.

Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension.

Å. Schwan, U. Brodin, J. Ostergren, 1998, American journal of hypertension.

CAPTOPRIL LOWERS URINARY KALLIKREIN IN HYPERTENSIVE PATIENTS

B. Karlberg, O. Nilsson, S. Wettre, 1980, The Lancet.

Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.

B. Hamrén, H Ericsson, B Hamrén, 2004, Drug metabolism and disposition: the biological fate of chemicals.

Urinary kallikrein, aldosterone, prostaglandin E2, sodium, potassium, and urinary volume in normal man-interrelations and day to day variation.

B. Karlberg, K. Ohman, 2009, Acta medica Scandinavica. Supplementum.

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

B. Karlberg, B. Kågedal, R. Larsson, 1985, Journal of cardiovascular pharmacology.

Interaction of prostaglandins with adenosine diphosphate induced increase in cytosolic free calcium in human platelets.

H. Keiser, J. Yun, K. Ohman, 1992, Scandinavian journal of clinical and laboratory investigation.

A population-based study of the white-coat blood pressure effect: positive correlation with plasma cortisol.

F. Nyström, E. Aardal, K. Ohman, 1998, Clinical and experimental hypertension.

Prizidilol (SKF 92657) in primary hypertension.

B. Karlberg, R. Larsson, K. Ohman, 1981, Clinical science.

Prizidilol, a combined vasodilatory and beta-adrenoceptor blocking drug, in primary hypertension. A long-term efficacy, tolerance and pharmacokinetic study.

B. Karlberg, J. Hed, B. Norlander, 1983, European journal of clinical pharmacology.

Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).

J. Gill, H. Keiser, J. Yun, 1991, Canadian journal of physiology and pharmacology.

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.

B. Karlberg, T. Lindström, U. Rosenqvist, 1987, The American journal of cardiology.

Pitfalls in Doppler evaluation of diastolic function: insights from 3-dimensional magnetic resonance imaging.

T Ebbers, L Wigström, A F Bolger, 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Circulating plasma prekallikrein and tissue kallikrein in normotensive and hypertensive humans: effects of angiotensin II infusion.

B. Karlberg, K. Ohman, K. P. Ohman, 1998, Clinical and experimental hypertension.

Captopril, aldosterone and urinary kallikrein in primary hypertension.

B. Karlberg, O. Nilsson, S. Wettre, 1983, Clinical and experimental hypertension. Part A, Theory and practice.

A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.

J. Atterhög, B. Karlberg, K. Tolagen, 2009, Acta medica Scandinavica.

Long-term experience of captopril in the treatment of primary (essential) hypertension.

B. Karlberg, J. Asplund, O. Nilsson, 1982, British journal of clinical pharmacology.